Toward intelligent hormonal diagnostics: Quantum dots reshaping endocrine disease detection

Area of Science:

• Biotechnology
• Nanotechnology
• Endocrinology

Background:

• Endocrine disorders require precise detection of low-abundance, fluctuating hormones.
• Traditional immunoassays have limitations in sensitivity, multiplexing, and signal stability.

Purpose of the Study:

• To review advancements in quantum dot (QD) technology for endocrine diagnostics.
• To explore the potential of QDs in multiplexed, ultrasensitive, and real-time hormonal biomarker detection.

Main Methods:

• Utilizing quantum dots with tunable emission for simultaneous biomarker monitoring.
• Engineering QDs with aptameric, peptidic, or antibody recognition domains.
• Integrating QDs with AI, microfluidics, and wearable biosensors for intelligent diagnostics.

Main Results:

• QDs provide high photostability, quantum-level sensitivity, and multiplexed detection capabilities.
• Functionalized QDs show promise for detecting insulin, estradiol, and thyroid hormones.
• AI-assisted QD systems enable trend prediction beyond static measurements.

Conclusions:

• Quantum dot technology is revolutionizing endocrine diagnostics with enhanced sensitivity and real-time capabilities.
• Integration with digital health platforms positions QDs for continuous monitoring and personalized hormonal medicine.
• Overcoming translational hurdles is key to clinical implementation of QD-enabled endocrine diagnostics.